Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
Tags:
JNJ, Actelion, clinical trials, M&A, antibiotics, cadazolid
Early use of J&J's Zytiga extends prostate cancer survival
Yahoo/Reuters
Sun, 06/4/17 - 11:46 am
Tags:
JNJ, Zytiga, prostate cancer, ASCO 2017
Ohio suit will be 'tough to win' for opioid drugmakers, analyst says
Fierce Pharma
Sun, 06/4/17 - 11:37 am
Tags:
Ohio, opioids, Teva, Allergan, JNJ, Purdue, Endo Health Solutions
J&J's Zytiga slashes death risk by 38% in earlier-stage prostate cancer patients
Fierce Pharma
Sat, 06/3/17 - 09:23 am
Tags:
JNJ, Zytiga, prostate cancer, ASCO 2017
Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
Endpoints
Sat, 06/3/17 - 09:17 am
Tags:
Minerva Neurosciences, MIN-202, JNJ, Actelion, insomnia, Iroko Pharmaceuticals
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
CNBC
Wed, 05/31/17 - 10:54 pm
Tags:
Ohio, opioid crisis, opioids, opioid abuse, JNJ, Janssen, Teva Pharmaceutical, Purdue Pharma, Allergan, Endo Health Solutions
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Fierce Biotech
Tue, 05/30/17 - 06:20 pm
Tags:
JNJ, Protagonist Therapeutics, M&A, Crohn's Disease, PTG-200
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Motley Fool
Tue, 05/30/17 - 10:05 am
Tags:
JNJ, Invokana, type 2 diabetes
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
Mon, 05/29/17 - 12:00 pm
Tags:
FDA, advisory panels, Pfizer, biosimilars, Amgen, Epogen, Procrit, anemia, JNJ
J&J settles OTC manufacturing issue for $33M
BioPharma Dive
Fri, 05/26/17 - 11:36 am
Tags:
JNJ, OTC, drug manufacturing, McNeil
J&J fires off legal salvo to block Samsung's Remicade biosim launch
Fierce Pharma
Fri, 05/19/17 - 11:30 am
Tags:
JNJ, Samsung Bioepis, Remicade, biosimilar
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug
Bloomberg
Thu, 05/18/17 - 10:01 pm
Tags:
FDA, JNJ, Risperdal, Janssen
J&J, steering through a rough patch, draws blockbuster roadmap with 11 new meds
Fierce Pharma
Wed, 05/17/17 - 11:44 am
Tags:
JNJ
J&J's Joaquin Duato: Diversity is 'essential'
Medical Marketing and Media
Wed, 05/17/17 - 09:38 am
Tags:
JNJ, diversity
J&J strikes settlement in ‘phantom’ Motrin recall suit
Fierce Pharma
Sat, 05/13/17 - 10:01 am
Tags:
JNJ, Motrin, product recalls
Johnson & Johnson appeal of $72M talc verdict could hinge on Bristol-Myers Squibb's SCOTUS case
Fierce Pharma
Thu, 05/11/17 - 06:25 pm
Tags:
JNJ, Bristol-Myers Squibb, Supreme Court
J&J discloses DOJ investigations into marketing, advisory practices
BioPharma Dive
Thu, 05/11/17 - 11:43 am
Tags:
JNJ, DOJ, drug marketing, Remicade, Olysio, Simponi, Stelara
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C meds
Fierce Pharma
Tue, 05/9/17 - 10:43 pm
Tags:
JNJ, drug manufacturing, immunology, hepatitis C, Remicade, Simponi, Stelara, Olysio
The Simple Reason Intuitive Surgical, Inc. Needn’t Worry About Competition
Motley Fool
Mon, 05/8/17 - 11:28 am
Tags:
Intuitive Surgical, devices, robotic surgery, JNJ, Alphabet, Transenterix
J&J loses latest talc verdict and ordered to pay $110M
Fierce Pharma
Fri, 05/5/17 - 10:23 am
Tags:
JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.